Journal profile · ENDOCRINOLOGY & METABOLISM

BMC Endocrine Disorders

ISSN 1472-6823 · BioMed Central · ENGLAND · Founded 2001

BMC Endocrine Disorders: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.65; fully open access; APC about USD 3,390; median 104 days to acceptance (159 articles, last 24 months); community-reported acceptance: fairly easy; 321 articles in 2025; indexed in SCIE and Scopus.

Impact factor3.65Latest value listed by LetPub
CAS zoneZone 3 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 3 · Medicine
Review time104 daysMedian, submission to acceptance · 159 articles, last 24 months · Crossref
APCUSD 3,390Fully open access
AcceptanceFairly easyCommunity average
Articles per year3212025 · OpenAlex count

Scope

Aims, scope and focus

BMC Endocrine Disorders is published by BioMed Central and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes, Cardiovascular Risks, and Lipoproteins, Thyroid Disorders and Treatments and Diabetes Management and Research, together about 26.8% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)

BMC Endocrine Disorders is an open access, peer-reviewed journal that considers articles on the characterization, prevention, diagnosis and treatment of endocrine disorders. The journal welcomes submissions covering the following broad areas of research: Clinical, basic and translational science studies that provide insights into the pathophysiology Molecular and cell biology Genetics, pharmacology, or epidemiology of endocrine disorders. Surgical advancements and new technologies aiding in the diagnosis, monitoring and computational modelling of endocrine disorders As a BMC Series journal, BMC Endocrine Disorders does not make editorial decisions based on the perceived interest or potential impact of a study. Manuscripts are considered for publication if they are scientifically valid. For research articles, this includes having a clearly defined and sound research question, appropriate methodology and analysis, and adherence to community-agreed standards relevant to the field.

From the journal's Aims & Scope

Research area (LetPub): ENDOCRINOLOGY & METABOLISM

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Diabetes, Cardiovascular Risks, and LipoproteinsMedicine13.4%
  2. Thyroid Disorders and TreatmentsMedicine7.6%
  3. Diabetes Management and ResearchMedicine5.8%
  4. Thyroid Cancer Diagnosis and TreatmentMedicine5.7%
  5. Diabetes Management and EducationMedicine5.5%
  6. Diabetes Treatment and ManagementMedicine5.3%
  7. Adipokines, Inflammation, and Metabolic DiseasesMedicine5.3%
  8. Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology4.4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorEndocrinology & MetabolismZone 3

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorEndocrinology & MetabolismZone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorEndocrinology & MetabolismZone 3

Top journal: noReview journal: no

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEEmbaseCASPublisher website

Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
3.65LetPub ·
Impact factor (publisher) 2025
3.7Publisher website ·
5-year impact factor (publisher) 2025
3.8Publisher website ·
CiteScore 2026-06
6.2LetPub ·
SJR 2026-06
1.02LetPub ·
SNIP 2026-06
1.26LetPub ·
h-index
33LetPub ·
h-index
84OpenAlex ·
i10-index
1,345OpenAlex ·
2-year mean citedness
3.09OpenAlex ·
Self-citation rate
2.7%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
316LetPub ·
Downloads per year (publisher) 2025
2,500,000Publisher website ·

Articles by year OpenAlex count · 2,879 in total · the current year is incomplete

YearArticlesOpen accessCitations
202644144180
20253213211,016
20242812812,131
20232772773,452
20223363365,897
20212472474,753

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

104 daysMedian, submission to acceptance · P25–P75 76 days – 193 days

Acceptance to online
median 9 days (159 articles)
Submission to online
median 124 days
Sample
159 articles with submission and acceptance dates (823 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
over 12 weeksLetPub ·
Average acceptance (community reports)
Fairly easyLetPub ·
Submission to first decision
7 daysPublisher website ·
Submission to publication (journal-reported)
about 23 weeksDOAJ ·
Peer review
Open peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJEUR 2,890 / USD 3,390 / GBP 2,590YesCC BY, CC BY-NC-ND
OpenAlexUSD 3,190 / EUR 2,690 / GBP 2,390——
LetPubGBP 2,190 / USD 2,990 / EUR 2,490Yes—
Publisher websiteGBP 2,590 / USD 3,390 / EUR 2,890——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Open calls for papers3, by deadline
  1. Disparities in the diagnosis and treatment of endocrine disordersDeadline
  2. Complications of type 1 diabetes: prevention and managementDeadline
  3. Diabetes and cardiovascular disease: new insights and treatmentsDeadline
Publisher website
What to prepare2 items from the author guidelines
Suggested reviewers
Optional
Not considered
Do not include any individual participant details.; Color and shading may not be used.; Commas should not be used to indicate numerical values.
Publisher website · model-extracted, each line checked against the text
Article types accepted9
  1. case reportResearch article Database article Software article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
  2. commentResearch article Database article Software article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
  3. database articleResearch article Database article Software article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
  4. matters arisingResearch article Database article Software article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
  5. research articleResearch article Database article Software article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
  6. reviewResearch article Database article Software article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
  7. software articleResearch article Database article Software article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
  8. study protocolResearch article Database article Software article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
  9. systematic reviewResearch article Database article Software article Case report Study protocol Review Matters Arising Comment Systematic ReviewLength not stated
Publisher website
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review
Authorship

Only authors may submit; third-party submission prohibited. Model summary

Please note that a manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.

Source ↗Publisher website ·
Conflicts of interest

Competing interests must be declared in the cover letter. Model summary

A declaration of any potential competing interests

Source ↗Publisher website ·
Data availability Formatting the 'Availability of data and materials' section of your manuscript

Editorial policies are available on the BioMed Central website. Model summary

The following format for the 'Availability of data and materials section of your manuscript should be used:

Source ↗Publisher website ·
License & copyright Licensing and copyright

Open access licensing under CC BY-NC-ND or CC BY. Model summary

Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. BMC Endocrine Disorders articles are published open access under a CC BY-NC-ND (Creative Commons Attribution…

Source ↗Publisher website ·
Open access Benefits of open access

Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…

Source ↗Publisher website ·
Peer review Peer review policy

Reviewer suggestions allowed with verifiable identity information. Model summary

Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
BioMed Central
Country or region
ENGLAND
Language
English
Founded
2001
ISSN
1472-6823
Official links

FAQ

Frequently asked questions about BMC Endocrine Disorders

What CAS zone is BMC Endocrine Disorders in?

In the 2025 upgraded edition of the CAS Journal Ranking, BMC Endocrine Disorders is in Zone 3 of Medicine, and in Zone 3 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of BMC Endocrine Disorders?

The latest impact factor listed by LetPub is 3.65; CiteScore 6.2, h-index 84.

How long does peer review take at BMC Endocrine Disorders?

Based on the dates recorded on 159 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 104 days (interquartile range 76–193 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index BMC Endocrine Disorders?

According to LetPub and DOAJ records, BMC Endocrine Disorders is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.

Is BMC Endocrine Disorders open access, and what is the APC?

BMC Endocrine Disorders is a fully open-access journal. APC about USD 3,390.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .